Zevia is executing a turnaround, with double-digit sales growth, narrowed losses, and strong brand appeal in the healthy soft drink segment. ZVIA is undervalued at a 0.6x price-to-sales ratio, offering significant upside if cost controls and commodity relief materialize. Expanded distribution, innovative marketing (including the Cardi B partnership), and loyal health-conscious consumers underpin robust demand and future growth.
Zevia PBC (ZVIA) Presents at Goldman Sachs Global Staples Forum 2026 Transcript
Zevia PBC (ZVIA) Q1 2026 Earnings Call Transcript
Zevia (ZVIA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago.
Zevia PBC (ZVIA) Q4 2025 Earnings Call Transcript
Zevia PBC is transitioning from a niche clean-label soda to a business with improving unit economics and broadening mainstream distribution. Gross margins have structurally improved to the mid-to-high 40% range, with positive adjusted EBITDA achieved for the first time in Q2 2025. Expanded Walmart distribution and a reliable supply chain underpin a flywheel for recurring growth, while management guides for 2026 profitability.
Zevia PBC ( ZVIA ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Amy Taylor - CEO, President & Director Girish Satya - EVP, CFO & Principal Accounting Officer Conference Call Participants Anne Mcguinness James Salera - Stephens Inc., Research Division Sarang Vora - Telsey Advisory Group LLC Andrew Strelzik - BMO Capital Markets Equity Research Eric Serotta - Morgan Stanley, Research Division Presentation Operator Greetings, and welcome to the Zevia PBC Q3 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Zevia (ZVIA) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.04 per share a year ago.
Zevia PBC targets the zero-sugar beverage trend with naturally sweetened sodas, teas, and energy drinks, appealing to health-conscious consumers. Zevia's financials show improving gross margins, stabilizing sales, and narrowing losses, supported by a debt-free balance sheet and expanding distribution. Valuation is attractive, significantly lower than peers like Celsius and Vita Coco, reflecting both risk and potential upside.
Zevia PBC (NYSE:ZVIA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Amy E. Taylor - CEO, President & Director Girish Satya - EVP, CFO & Principal Accounting Officer Conference Call Participants Daniel Alan Goldman - Unidentified Company BMO Capital Markets Corp. - Unidentified Company Ethan David Huntley - Goldman Sachs Group, Inc., Research Division James Ronald Salera - Stephens Inc., Research Division Sarang Vora - Telsey Advisory Group LLC Jean Fontana - Unidentified Company Operator Good day, everyone, and welcome to today's Zevia's Second Quarter 2025 Earnings Call.
Zevia (ZVIA) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.09 per share a year ago.
Does Zevia (ZVIA) have what it takes to be a top stock pick for momentum investors? Let's find out.